This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. (June 2019) |
This article relies largely or entirely on a single source. (October 2024) |
Ortho-McNeil-Janssen Pharmaceuticals, Inc is a healthcare company of Johnson & Johnson composed of two divisions:
- Ortho-McNeil, based in Raritan, NJ (United States); the division is focused on primary care.[1]
- Janssen, based in Beerse (Belgium); formerly Janssen Pharmaceutica; the division is focused on mental health.[2]
After some suits against Ortho-McNeil, Johnson & Johnson came to an agreement about the future of this subsidiary branch, now known as Janssen Pharmaceuticals.
See also
editReferences
edit- ^ "Johnson & Johnson Creates Primary Care Unit From Ortho-McNeil And Janssen". Pink Sheet. 2005-12-19. Retrieved 2024-10-13.
- ^ "Case Study: Janssen Pharmaceutica ' | ipl.org". www.ipl.org. Retrieved 2024-10-13.
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |